Search research articles
Contact Us
Filters
Showing results (511-520 of 721) with videos related to
Page
of 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study
Lena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 4, 2024
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in <i>EGFR</i>-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
Martin Schuler, Jörg Hense, Kaid Darwiche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2008
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine
Andreas K Buck, Ken Herrmann, Christian Meyer Zum Büschenfelde, et al.
Plos One
|
November 27, 2023
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol
Aashna Karbhari, Sherly Mosessian, Kamaxi H Trivedi, et al.
European Urology
|
September 6, 2024
Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [<sup>177</sup>Lu]Lu-PSMA-617 in the Phase 3 VISION Trial
Andrew J Armstrong, Oliver Sartor, Johann de Bono, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0
Emil Novruzov, Gabriel T Sheikh, Eduards Mamlins, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2023
Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma
Marnix Lam, Etienne Garin, Xavier Palard-Novello, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2023
EANM position paper: theranostics in brain tumours-the present and the future
Nelleke Tolboom, Antoine Verger, Nathalie L Albert, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 10, 2025
Staging of prostate Cancer with ultra-fast PSMA-PET scans enhanced by AI
David Kersting, Katarzyna Borys, Alina Küper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2025
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization
Steven P Rowe, Brian M Shuch, Mark W Ball, et al.
Page
of 73
Search research articles
Search
Showing results (511-520 of 721) with videos related to
Sort By:
Page
of 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study
Lena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 4, 2024
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in <i>EGFR</i>-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
Martin Schuler, Jörg Hense, Kaid Darwiche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2008
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine
Andreas K Buck, Ken Herrmann, Christian Meyer Zum Büschenfelde, et al.
Plos One
|
November 27, 2023
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol
Aashna Karbhari, Sherly Mosessian, Kamaxi H Trivedi, et al.
European Urology
|
September 6, 2024
Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [<sup>177</sup>Lu]Lu-PSMA-617 in the Phase 3 VISION Trial
Andrew J Armstrong, Oliver Sartor, Johann de Bono, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0
Emil Novruzov, Gabriel T Sheikh, Eduards Mamlins, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2023
Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma
Marnix Lam, Etienne Garin, Xavier Palard-Novello, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2023
EANM position paper: theranostics in brain tumours-the present and the future
Nelleke Tolboom, Antoine Verger, Nathalie L Albert, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 10, 2025
Staging of prostate Cancer with ultra-fast PSMA-PET scans enhanced by AI
David Kersting, Katarzyna Borys, Alina Küper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2025
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization
Steven P Rowe, Brian M Shuch, Mark W Ball, et al.
Page
of 73